is mounjaro glp 1 (tirzepatide) a dual incretin agonist targeting both GLP-1 and GIP receptors. It improves glycaemic control by enhancing insulin secretion, suppressing glucagon, and delaying gastric emptying — which also leads to What are GLP-1 drugs? The

Different Plaque Deposits It's not just anatomical differences - the way that arterial plaques and injuries show up in women can be very different from men, delaying a heart disease diagnosis, or even misdiagnosing it

Modulation and block of ion channels: A new biology of polyamines

These effects are observed in experimental settings, but there is no established safe dose for human use from clinical trials

2011;3:CD007749

These large reductions in weight by current incretin therapeutics have translated into improvements in cardiovascular health

Important considerations before switching GLP-1 therapy The following are important considerations before switching GLP-1 medications: Oral vs